CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies. CCRM is supported by the Centres of Excellence for Commercialization and Research (CECR) program.
Regenerative medicine, which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today.
Many new and potentially life-changing regenerative medicine-based treatments never reach patients because they are not successfully moved from the laboratory to the clinic. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and bioengineers have come together to form the Centre for Commercialization of Regenerative Medicine (CCRM).